nafazatrom has been researched along with Pituitary Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bjøro, T; Englund, K; Haug, E; Torjesen, PA | 1 |
Judd, AM; Koike, K; Login, IS; MacLeod, RM; Yasumoto, T | 1 |
2 other study(ies) available for nafazatrom and Pituitary Neoplasms
Article | Year |
---|---|
Inhibitors of the arachidonic acid metabolism attenuate the thyroliberin (TRH) stimulated prolactin production without modifying the production of inositolphosphates in GH4C1 pituitary cells.
Topics: 5,8,11,14-Eicosatetraynoic Acid; Animals; Arachidonic Acid; Inositol Phosphates; Lipoprotein Lipase; Lipoxygenase Inhibitors; Phospholipases A; Phospholipases A2; Pituitary Neoplasms; Prolactin; Pyrazoles; Pyrazolones; Quinacrine; Rats; Thyrotropin-Releasing Hormone; Tumor Cells, Cultured | 1993 |
Maitotoxin, a calcium channel activator, increases prolactin release from rat pituitary tumor 7315a cells by a mechanism that may involve leukotriene production.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Calcium; Cell Line; Indomethacin; Ion Channels; Marine Toxins; Oxocins; Pituitary Neoplasms; Prolactin; Prostaglandins; Pyrazoles; Pyrazolones; Rats; SRS-A | 1986 |